Student Message Board

Pharmaceutical Industry in Syria

The aim of this article is to presentthe development of the pharmaceutical industry in Syria using national andinternational public data sources. At the end of the 80ies, the pharmaceuticalindustry in Syriawas very poor, covering 6% of the national needs. In less than 20 years, withthe government support in terms of legal frame and strategic politicalengagement, the Syrian pharmaceutical industry finally covered almost 90% ofthe national needs, in terms of drugs, and exported drugs in around 52 Arabiancountries. Beyond covering the local market, the main added values of this hugedevelopment consisted in exporting drugs in amount of 150 million dollars per yearand providing jobs for 17000 Syrian people, out of which around 85% are women.Strong and weak points of the pharmaceutical sector are taken intoconsideration in the article and further interventions to support a sustainabledevelopment are proposed by the author.

606 views

Influence of personalized therapeutic approach on quality of life...

Personalized medical care has been consistently proven in literature as contributing to the maintenance of psychological balance and quality of life in patients suffering from chronic conditions. However, limited research has investigated the role of personalized approach in improving these parameters in patients with advanced incurable diseases. The scope of this paper was to investigate the possible impact of personalized care condition in advanced colon cancer patients, requiring palliative care. 60 patients (32 M, 28 F) (mean age 64,6) suffering from this disease were randomly assigned to a standard or to a personalized care condition. The latest implied (a) frequent (at least 2 monthly) meetings with the doctor, (b) possibility to be involved in treatment decisions, (c) more information given about diagnosis and prognosis and (d) psychological support provided to the patient and his/her family members, to deal better with daily problems and needs. The design of the study was prospective and consisted of two successive evaluations of quality of life (SF-36 questionnaire) and anxiety and depression (HAD test). Cancer patients pertaining to the personalized treatment approach had both superior quality of life scores (p < 0,05) and lower anxiety (p < 0,01) and depression (p < 0,05) than the control group. A more detailed analysis showed significant differences of vitality and social functioning for subjects pertaining to the study group (p < 0,05), as well as a lower ratio between latent and manifest anxiety (p < 0,01). These results argue in favor of the benefits of a personalized treatment approach for patients with advanced incurable diseases.

414 views